Here are the dozens of weight loss drugs in development to catch a booming market
Want to know which drugs could soon compete with Wegovy or Mounjaro? The STAT Obesity Drug Tracker is following dozens of candidates.
Related Articles
Drinking coffee may help prevent mental decline in people with atrial fibrillation
Research Highlights: A study of more than 2,400 people with atrial fibrillation, who had an average age of 73, found that drinking more than five…
Coronary Subclavian Steal Syndrome | NEJM
A 63-year-old man with a history of CABG presented with a 2-month history of angina during exertion of the left arm. Angiography revealed retrograde flow…
RAG Crash Course – Daily Dose of Data Science
A deep dive into handling multiple data types in RAG systems faster (with implementations). A deep dive into making RAG systems faster (with implementations). A…
Clinical impact of novel cardiovascular magnetic resonance technology on patients with congenital heart disease: a scientific statement of the Association for European Pediatric and Congenital Cardiology and the European Association of Cardiovascular Imaging of the European Society of Cardiology
Abstract. Cardiovascular magnetic resonance (CMR) imaging is recommended in patients with congenital heart disease (CHD) in clinical practice guidelines as
Clinical Research Fellows (RA2284) in University of East Anglia | UEA
View details and apply for this Clinical Research Fellows (RA2284) vacancy in University of East Anglia. Faculty of Medicine and Health Sciences Norwich Medical School…
ACCEL Lite: Top Takeaways from 2024: EP with Dhanunjaya Lakkireddy, MD, MBA, FACC – American College of Cardiology
In this interview, Dhanunjaya Lakkireddy, MD, MBA, FACC, and Alison L. Bailey, MD FACC, discuss the Top Electrophysiology (EP) Takeaways from 2024. Dr. Lakkireddy discusses…
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO)
A novel transcatheter tricuspid valve therapy device, the Tricuspid Flow Optimizer (TRiFlO), for the treatment of severe tricuspid regurgitation.
No One Talks about Vasoplegia
This webinar will discuss pathophysiology of vasoplegia and its implications in the management of patients receiving short and long-term mechanical circulatory support. Finally, we will…
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
Effect of sodium-glucose co-transporter-2 inhibitors on arterial stiffness: A systematic review and meta-analysis of randomized controlled trials – Dimitrios Patoulias, Christodoulos Papadopoulos, George Kassimis, Nikolaos Fragakis, Vassilios Vassilikos, Asterios Karagiannis, Michael Doumas, 2022
Background: Arterial stiffness represents an established cardiovascular risk marker. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have significant cardio…
